Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Return on Equity (2018 - 2025)

Historic Return on Equity for Sutro Biopharma (STRO) over the last 8 years, with Q3 2025 value amounting to 3.45%.

  • Sutro Biopharma's Return on Equity rose 44000.0% to 3.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.45%, marking a year-over-year increase of 44000.0%. This contributed to the annual value of 2.34% for FY2024, which is 17600.0% down from last year.
  • Per Sutro Biopharma's latest filing, its Return on Equity stood at 3.45% for Q3 2025, which was up 44000.0% from 6.84% recorded in Q2 2025.
  • In the past 5 years, Sutro Biopharma's Return on Equity ranged from a high of 6.84% in Q2 2025 and a low of 24.97% during Q1 2025
  • Moreover, its 5-year median value for Return on Equity was 0.62% (2022), whereas its average is 1.44%.
  • Data for Sutro Biopharma's Return on Equity shows a peak YoY increase of 78300bps (in 2025) and a maximum YoY decrease of -240400bps (in 2025) over the last 5 years.
  • Quarter analysis of 5 years shows Sutro Biopharma's Return on Equity stood at 0.35% in 2021, then plummeted by -51bps to 0.53% in 2022, then crashed by -53bps to 0.82% in 2023, then tumbled by -258bps to 2.92% in 2024, then surged by 218bps to 3.45% in 2025.
  • Its Return on Equity was 3.45% in Q3 2025, compared to 6.84% in Q2 2025 and 24.97% in Q1 2025.